Tag: Healthcare Innovation Award

Strengths for the Awards✨

Outstanding Research Contributions – Dr. Han has led multiple impactful research projects, including those on neonatal diseases, human milk research, and preterm infant care. Her work on NEC prevention and neonatal hyperbilirubinemia has resulted in significant clinical advancements.
High Research Output – With 35 SCI/Scopus-indexed journal publications, books, and patents, she has established a strong research profile.
National and International Recognition – Her research has been recognized with prestigious awards such as the Jiangsu Medical Science and Technology Award and the National Maternal and Child Health Science and Technology Award (2023).
Clinical Impact – Her work has led to real-world applications, such as reducing NEC incidence and influencing national healthcare guidelines.
Leadership and Collaboration – She holds key positions in professional organizations, editorial boards, and multidisciplinary collaborations, showing her influence in the field.

Education 🎓

Dr. Han obtained her Doctor of Pediatrics degree and pursued further studies at top medical institutions, including the Children’s Hospital of Fudan University (Shanghai), Denver Children’s Hospital (University of Colorado, USA), and Philadelphia Children’s Hospital (University of Pennsylvania, USA). Her academic journey has equipped her with cutting-edge knowledge and skills in neonatal and pediatric medicine.

Experience 💼

With decades of experience, Dr. Han is the Administrative Director of the Department of Pediatrics at the Obstetrics and Gynecology Hospital affiliated with Nanjing Medical University. She has led key neonatal healthcare initiatives and played an instrumental role in establishing Jiangsu Provincial Key Clinical Specialty in Neonatology. Her leadership has contributed to advancements in neonatal disease diagnosis and treatment.

Research Interests On Medicine 🌍

Dr. Han’s research focuses on preterm-related diseases, human milk studies, and neonatal hyperbilirubinemia. Her work explores necrotizing enterocolitis (NEC) and bronchopulmonary dysplasia (BPD), aiming to develop innovative prevention strategies. She has conducted multi-center studies on severe complications in preterm infants and the protective effects of human milk-derived peptides, advancing neonatal healthcare globally.

Awards 🏆

Dr. Han’s contributions have earned her prestigious accolades, including:

Jiangsu Medical Science and Technology Award (2023)
National Maternal and Child Health Science and Technology Award (2023) Her groundbreaking research and dedication to neonatal care have positioned her as a leading expert in the field.

Publications 📚

Dr. Han has authored over 35 papers in SCI/Scopus-indexed journals. Some of her notable publications include:

Effect of probiotics on necrotizing enterocolitis in preterm infants: a network meta-analysis of randomized controlled trials
- Authors: Y. Dai, Q. Yu, F. Zhang, S. Li, S. Han
- Publication Year: 2025
Association between antenatal corticosteroids and neonatal outcomes among very preterm infants born to mothers with hypertensive disorders of pregnancy: a multicenter cohort study
- Authors: M. Sun, A. Qian, X. Li, T. Yang, L. Yuan
- Publication Year: 2025
The current clinical landscape of preterm infants less than 32 weeks of gestation receiving delivery room chest compression in Jiangsu Province, China
- Authors: N. Wang, W. Hou, H. Zhou, J. Zhang, R. Cheng
- Publication Year: 2025
Risk factors and adverse outcomes of initial non-invasive ventilation failure in very low birth weight infants: a multicenter retrospective cohort study
- Authors: J. Zhu, S. Li, Y. Gao, S. Han
- Publication Year: 2024
Conjugated linoleic acid ameliorates necrotizing enterocolitis by suppressing inflammatory responses and maintaining intestinal barrier integrity via the PPARγ/NFκB signaling pathway
- Authors: C. Jiang, F. Zhang, M. Zhang, S. Li, S. Han
- Publication Year: 2024
Association of neonatal outcome with birth weight for gestational age in Chinese very preterm infants: a retrospective cohort study
- Authors: L. Li, J. Guo, Y. Wang, W. Zhou, L. Du
- Publication Year: 2024
RBC transfusion and necrotizing enterocolitis in very preterm infants: a multicenter observational study
- Authors: D. Dang, X. Gu, S. Jiang, Y. Wu, J.Y. Ting
- Publication Year: 2024
The performance of the practices associated with the occurrence of severe intraventricular hemorrhage in the very premature infants: data analysis from the Chinese neonatal network
- Authors: T. Xiao, L. Hu, H. Chen, Y. Chen, Y. Wu
- Publication Year: 2024
Using a new human milk fortifier to optimize human milk feeding among very preterm and/or very low birth weight infants: a multicenter study in China
- Authors: J. Han, L. Zhang, R. Zhang, C. Liu, Y. Cao
- Publication Year: 2024
Neonatal lupus erythematosus with severe persistent pulmonary hypertension

Authors: B. Zhuang, Y. Chen, S. Han
Publication Year: 2024

Conclusion 📄

Dr. Shuping Han’s exemplary career in neonatology has made a profound impact on neonatal care and maternal-child health. Through her research, leadership, and clinical expertise, she has improved preterm infant outcomes and influenced healthcare policies. Her dedication to innovation and mentorship continues to shape the future of neonatal medicine, solidifying her reputation as a pioneer in the field.

Mohamad Taleuzzaman | Pharmacology | Best Researcher Award

Posted on 02/04/202502/04/2025 by sciencefather

Prof. Dr. Mohamad Taleuzzaman | Pharmacology | Best Researcher Award

Maulana Azad University | India

Dr. Mohamad Taleuzzaman is a distinguished academician and researcher in the field of pharmaceutical chemistry. With a career spanning over 15 years, he has contributed significantly to pharmaceutical education, research, and administration. Currently serving as a Professor and Head of the Department at Maulana Azad University, Jodhpur, his expertise lies in pharmaceutical analysis, drug development, and bioanalytical research. Passionate about scientific innovation, he has played a vital role in mentoring students and advancing pharmaceutical sciences.

Professional profile👤

Strengths for the Awards✨

Extensive Research Contributions – Dr. Taleuzzaman has numerous publications in high-impact journals, showcasing his active engagement in research.
Diverse Research Interests – His work spans pharmaceutical chemistry, nanotechnology, molecular docking, and bioanalytical method development.
Academic Leadership – Serving as a Professor and HOD, he has contributed to institutional development and research coordination.
Patent Holder – His patent on a polymeric nano scaffold for anti-diabetic applications highlights his innovation.
Mentorship – He has successfully guided Ph.D. and M.Pharm students, contributing to academic growth.
Strong Administrative Experience – Coordinating academic inspections, examinations, and regulatory compliance.

Education 🎓

Dr. Taleuzzaman pursued his Ph.D. in Pharmaceutical Chemistry from Glocal University, Saharanpur, in 2018. He completed his M.Pharm in Pharmaceutical Analysis from Jamia Hamdard, New Delhi, securing a first-class distinction with 73.84% in 2007. His academic journey began with a B.Pharm from the same institution in 2005. Additionally, he qualified for the GATE examination in 2005 with an impressive percentile of 92.49, further solidifying his strong foundation in pharmaceutical sciences.

Professional Experience 💼

With over 15 years of professional experience, Dr. Taleuzzaman has held key positions in both academia and the pharmaceutical industry. Since 2019, he has been serving as a Professor and HOD at Maulana Azad University, Jodhpur. Prior to this, he worked as an Associate Professor at Glocal School of Pharmacy, Saharanpur, and as an Assistant Professor at KIET School of Pharmacy, Ghaziabad. His industrial experience includes roles such as Product Development Manager at Ultra Biolabs Pvt. Ltd., Chandigarh, and Quality Officer at Ali & Abdul Karim Trading Co., Oman.

Research Interests On Pharmacology 📚

Dr. Taleuzzaman’s research is centered on pharmaceutical analysis, drug formulation, and bioanalytical method development. His Ph.D. research focused on the extraction, characterization, and quantification of thymoquinone and eugenol from Nigella sativa and Myristica fragrans. He has also explored novel drug delivery systems, nanotechnology applications in pharmaceuticals, and synthetic methodologies for bioactive compounds.

Awards & Recognitions 🏆

Dr. Taleuzzaman has been recognized for his contributions to pharmaceutical sciences and academic excellence. His innovative research has led to a patent titled “Sitagliptin loaded polymeric nano scaffold for enhanced anti-diabetic performance” (Patent number: 2021104076). He has also been actively involved in coordinating major academic accreditations such as PCI, UGC, and NAAC inspections at leading pharmacy institutions.

Publications 📄

Dr. Taleuzzaman has published extensively in high-impact journals. Some of his notable research articles include:

Ultra performance liquid chromatography (UPLC)-a review
Authors: M Taleuzzaman, S Ali, SJ Gilani, SS Imam, A Hafeez
Year: 2015
Citations: 133
Limit of blank (LOB), limit of detection (LOD), and limit of quantification (LOQ)
Author: M Taleuzzaman
Year: 2018
Citations: 88
Eugenol as a potential drug candidate: A review
Authors: M Taleuzzaman, P Jain, R Verma, Z Iqbal, MA Mirza
Year: 2021
Citations: 79
Clarithromycin-loaded ocular chitosan nanoparticle: formulation, optimization, characterization, ocular irritation, and antimicrobial activity
Authors: M Bin-Jumah, SJ Gilani, MA Jahangir, A Zafar, S Alshehri, M Yasir, C Kala, …
Year: 2020
Citations: 70
Quality by design (Qbd) assisted development of phytosomal gel of aloe vera extract for topical delivery
Authors: P Jain, M Taleuzzaman, C Kala, D Kumar Gupta, A Ali, M Aslam
Year: 2021
Citations: 48
Nano phytomedicine based delivery system for CNS disease
Authors: MA Jahangir, C Anand, A Muheem, SJ Gilani, M Taleuzzaman, A Zafar, …
Year: 2020
Citations: 44
Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments
Authors: I Rahat, SS Imam, M Rizwanullah, S Alshehri, M Asif, C Kala, …
Year: 2021
Citations: 36
Benzothiazole incorporated thiazolidin-4-ones and azetidin-2-ones derivatives: Synthesis and in vitro antimicrobial evaluation
Authors: SJ Gilani, K Nagarajan, SP Dixit, M Taleuzzaman, SA Khan
Year: 2016
Citations: 30
Phytosomal gel of Manjistha extract (MJE) formulated and optimized with central composite design of Quality by Design (QbD)
Authors: M Taleuzzaman, A Sartaj, D Kumar Gupta, SJ Gilani, MA Mirza
Year: 2023
Citations: 29
Formulation and evaluation of thymoquinone niosomes: Application of developed and validated RP-HPLC method in delivery system
Authors: SJ Gilani, SS Imam, A Ahmed, S Chauhan, MA Mirza, M Taleuzzaman
Year: 2019
Citations: 28

Conclusion 🔗

Dr. Mohamad Taleuzzaman’s dedication to pharmaceutical research and education has made a profound impact on the field. His work in drug development, bioanalytical chemistry, and nanotechnology has contributed to the advancement of pharmaceutical sciences. As a mentor, researcher, and academic leader, he continues to inspire and shape the future of pharmaceutical research.

Arvind Kumar Patel | Pharmacology | Best Researcher Award

Posted on 28/03/202528/03/2025 by sciencefather

Dr. Arvind Kumar Patel | Pharmacology | Best Researcher Award

Narayan Institute of Pharmacy, Gopal Narayan Singh University | Bihar, India

Dr. Arvind Kumar Patel is a dedicated academician and researcher in the field of Pharmacology. With a strong commitment to education and research, he has made significant contributions to the pharmaceutical sciences. His expertise lies in pharmacological studies, toxicology, and herbal medicine research, aiming to enhance therapeutic approaches for various ailments. His passion for teaching and research continues to inspire students and professionals alike.

Professional profile👤

Strengths for the Awards✨

Extensive Research Contributions:
- Published multiple research and review papers in reputed journals, including Scopus and Web of Science indexed journals.
- Focused research on pharmacology, particularly on allergic conjunctivitis, toxicology, and phytopharmaceuticals, showcasing expertise in niche areas of pharmacology.
Academic and Professional Excellence:
- Earned a Ph.D. in Pharmacology with a robust academic background.
- Currently serving as an Assistant Professor, contributing to the field through teaching and mentoring.
- Experience in multiple institutions, enriching his teaching and research acumen.
Innovative Research and Publications:
- Contributed book chapters and authored a book on Pharmacology aligned with the PCI syllabus.
- Presented research findings at various international and national conferences, demonstrating active participation in scientific discussions.
Technical Proficiency:
- Skilled in pharmacological screening, drug formulation processes, and animal handling.
- Well-versed in research methodologies, experimental design, and analytical techniques.
Awards and Recognitions:
- Received awards such as Best Student of the Year and 1st prize in poster presentations, showcasing his dedication and competence.
- Honored with titles such as “Mr. Perfect,” reflecting his well-rounded personality.

Education 🎓

Dr. Patel pursued his Ph.D. in Pharmacy from IFTM University, Moradabad, India, in 2023. He completed his M. Pharm in Pharmacology from the same university in 2017, securing an impressive 83.50%. His foundational education in pharmacy was obtained from Ashoka Institute of Technology & Management, Varanasi, where he earned his B. Pharm degree in 2015. His academic journey was rooted in a strong foundation laid at Mahabodhi Inter College, Varanasi.

Experience 🌟

Dr. Patel is currently serving as an Assistant Professor at Narayan Institute of Pharmacy, Gopal Narayan Singh University, Bihar, since June 2024. Previously, he gained valuable teaching experience at Baba Baijnath College of Pharmacy, Azamgarh, for two years and at Apex Institute of Pharmacy, Mirzapur, for five years. His vast teaching experience has equipped him with deep insights into pharmaceutical sciences and student mentorship.

Research Interest On Pharmacology 📚

His research interests revolve around pharmacological screening, herbal medicine, and drug toxicity studies. His notable research includes investigations into the anti-allergic conjunctivitis effects of medicinal plants and toxicity studies of plant extracts. His work aims to bridge the gap between traditional medicine and modern pharmacological advancements.

Awards & Achievements 🏆

Dr. Patel has received multiple accolades for his contributions to pharmaceutical sciences, including:

1st Prize in Poster Presentation at ABHYUDAY (2014), Annual Fest of Ashoka Institute of Technology & Management.
Best Student of the Year (2015) at Ashoka Institute of Technology & Management.
Honored as Mr. Perfect (2015) in his farewell event.

Publications 📝

Dr. Patel has authored several research papers, review articles, and book chapters in reputed journals and publishing platforms. Some of his notable publications include:

Title: Thermodynamic life cycle assessment of humans with considering food habits and energy intake
Authors: AK Patel, SPS Rajput
Year: 2020
Citations: 10
Title: Effects of nanofluid flow in micro channel heat sink for forced convection cooling of electronics device: a numerical simulation
Authors: AK Patel, S Bhuvad, SPS Rajput
Year: 2019
Citations: 10
Title: Design and heat transfer performance analysis of mini-channel heat sink with water, EG and EG20 based nanofluids-computational approach
Authors: AK Patel, SPS Rajput, R Kumar, A Sharma, AP Singh, MK Sharma, …
Year: 2022
Citations: 9
Title: Numerical analysis of micro-channel heat sink using ethylene glycol based nanofluid in case of electronics cooling
Authors: SS Bhuvad, AK Patel, SPS Rajput
Year: 2020
Citations: 3
Title: Parametric Analysis of Energy and Exergy of the human body in Indian conditions
Authors: SP Arvind Kumar Patel
Year: 2020
Citations: 2
Title: A review on human biological material-types, uses, storage and disposal
Authors: AK Patel, SPS Rajput
Year: 2019
Citations: 2
Title: CFD Analysis for Heat Transfer Enhancement of Microchannels Heat Sink Using Nanofluid Flow in Case of Electronics Device
Authors: SS Bhuvad, AK Patel, SPS Rajput
Year: 2020
Citations: 1
Title: Entropy production and Human life cycle assessment for Indians with considering protein, fat, and carbohydrate
Authors: SP Arvind Kumar Patel
Year: 2020
Title: Simulation of Natural Draft wet cooling tower with variation of Air inlet height through Computational Fluid Dynamics
Authors: AS Arvind Kumar Patel
Year: 2013

Conclusion 📝

Dr. Arvind Kumar Patel is a committed educator, researcher, and pharmacologist with a deep passion for advancing the field of pharmaceutical sciences. His contributions to research and academia continue to benefit students and professionals, furthering innovations in herbal pharmacology and drug toxicity studies. Through his dedication and expertise, he aspires to make a lasting impact in the domain of pharmacy and healthcare.

Zhanbo Qu | Medicine | Best Researcher Award

Posted on 25/03/202525/03/2025 by sciencefather

Dr. Zhanbo Qu | Medicine | Best Researcher Award

Huzhou central hospital | China

Dr. Qu Zhanbo is a dedicated medical professional at Huzhou Central Hospital, with a focus on microbiology, oncology, and gastroenterology. As a researcher, Dr. Qu has made significant contributions to the scientific community, publishing multiple papers in esteemed journals. His academic journey is marked by exceptional achievements, including being recognized as a top graduate innovative talent during his master’s studies.

Professional profile👤

Strengths for the Awards✨

Research Productivity: Qu Zhanbo has published 2 SCI papers as the first author, 3 SCI papers as a total of first author, and contributed to 16 SCI papers overall. This demonstrates consistent research output and collaboration.
Interdisciplinary Focus: His research spans microbiology, oncology, and gastroenterology — fields with significant impact on healthcare, especially in understanding colorectal cancer risk.
Recognition and Innovation: Awarded as a top graduate Innovative Talent during his master’s studies, reflecting early recognition for his research potential.
Patent Development: Involved in the development of dissolving microneedles of Clostridium butyricum and oxaliplatin, indicating a focus on translational research and innovation.
Diverse Publications: Contributions to reputable journals like Aging and Disease, Aging-US, Digestion, and Microbial Biotechnology highlight his research’s acceptance in well-regarded scientific communities.

Education 🎓

Dr. Qu Zhanbo pursued his medical education with a deep interest in understanding complex diseases and their microbial interactions. His academic path laid the foundation for his subsequent research endeavors, where he explored the intersection of microbiology and oncology.

Experience 💼

Currently serving at Huzhou Central Hospital, Dr. Qu combines clinical practice with groundbreaking research. His work spans various domains, including the association of Peptostreptococcus stomatis with colorectal cancer risk. Over the years, he has authored multiple SCI papers and contributed extensively to scientific literature, showcasing his expertise and commitment to advancing medical knowledge.

Research Interests On Medicine🔬

Dr. Qu’s research interests lie at the crossroads of microbiology, oncology, and gastroenterology. His investigations delve into microbial influences on cancer development, aiming to uncover novel insights that could lead to improved diagnostic and therapeutic strategies.

Awards 🏆

Dr. Qu’s academic and research excellence have been recognized through several accolades, including being awarded as a top graduate innovative talent during his master’s studies. This honor reflects his exceptional contributions to scientific inquiry and innovation.

Publications 📖

Dr. Qu has an impressive publication record, with notable papers such as:

Multiple primary malignancies and gut microbiome
- Year: 2025
- Authors: Yinhang Wu, Zhanbo Qu, Zheng Wu, Jing Zhuang, Yingchen Wang, Zefeng Wang, Jian Chu, Quan Qi, Shuwen Han
Fecal occult blood affects intestinal microbial community structure in colorectal cancer
- Year: 2025
- Authors: Wu Guodong, Wu Yinhang, Wu Xinyue, Shen Hong, Chu Jian, Qu Zhanbo, Han Shuwen
Aging Gut Microbiome in Healthy and Unhealthy Aging
- Year: 2024
- Authors: Zhanbo Qu
Classification of Colorectal Cancer Subtypes Based on Endoplasmic Reticulum Stress
- Year: 2024
- Authors: Zhanbo Qu, Jian Chu, Yinhang Wu, Jing Zhuang, Jiang Liu, Shugao Han, Wei Wu, Shuwen Han
Escherichia coli on colorectal cancer: A two‐edged sword
- Year: 2024 (October)
- Authors: Chu Jian, Wu Yinhang, Zhuang Jing, Qu Zhanbo, Wang Zefeng, Shuwen Han
Deep learning application in prediction of cancer molecular alterations based on pathological images: a bibliographic analysis via CiteSpace
- Year: 2024 (October)
- Authors: Yu Xiaojian, Qu Zhanbo, Chu Jian, Wang Zefeng, Liu Jian, Liu Jin, Pan Yuefen, Han Shuwen
Third-generation PacBio sequencing to explore gut bacteria and gender in colorectal cancer
- Year: 2024 (July)
- Authors: Sheng Yu, Jian Chu, Yinhang Wu, Jing Zhuang, Zhanbo Qu, Yifei Song, Xinyue Wu, Shuwen Han
Age and aging process alter the gut microbes
- Year: 2024 (April 8)
- Authors: Qu Zhanbo, Zhuang Jing, Han Shugao, Wu Yinhang, Chu Jian, Yu Xiang, Zhao Feimin, Liu Jian, Wu Xinyue, Wu Wei et al.
Transcriptional profile and immune infiltration in colorectal cancer reveal the significance of inducible T‐cell costimulator as a crucial immune checkpoint molecule
- Year: 2024 (March)
- Authors: Jian Chu, Yinghang Wu, Zhanbo Qu, Jing Zhuang, Jiang Liu, Shugao Han, Wei Wu, Shuwen Han
Identification of enterotype and its predictive value for patients with colorectal cancer

Year: 2024 (February 27)
Authors: Li Qingbo, Zhuang Jing, Qu Zhanbo, Chu Jian, Song Yifei, Wu Yinhang, Han Shuwen

Conclusion 🔝

Dr. Qu Zhanbo stands out as a passionate researcher and dedicated doctor whose work bridges clinical practice and scientific exploration. His contributions to microbiology, oncology, and gastroenterology continue to shape the understanding of disease mechanisms and pave the way for future innovations in medical science.

Jinhui Ma | Medicine | Best Researcher Award

Posted on 17/03/202517/03/2025 by sciencefather

Dr. Jinhui Ma | Medicine | Best Researcher Award

Associate doctor | China-Japan Friendship Hospital | China

A dedicated orthopedic specialist at China-Japan Friendship Hospital, Department of Bone and Joint Surgery, serving as an Associate Chief Physician, with profound expertise in diagnosing and treating complex bone and joint conditions. His commitment to advancing orthopedic care is exemplified by his contributions to clinical research, academic publications, and medical education.

Professional profile👤

Strengths for the Awards✨

Extensive Clinical Expertise: Specializes in diagnosing and treating complex bone and joint diseases, with a focus on early treatment of osteonecrosis of the femoral head and hip preservation techniques.
Research Excellence: Has led notable research projects, including one funded by the Beijing Natural Science Youth Fund and another by the China-Japan Friendship Hospital, while contributing to three National Natural Science Foundation projects.
Publication Record: As first and co-first author, has published 17 SCI articles and nearly 8 core journal articles, showcasing a strong contribution to the academic community.
Academic Contributions: Participated in compiling three orthopedic books and contributed to the development of two utility model patents.
Recognition and Awards: Recipient of the “Outstanding Scientific Research Award” and “Excellent Graduate” award from Peking University, reflecting research excellence.
Professional Engagement: Active involvement in academic exchanges at international and national conferences, including ASIA, COA, and BOA, highlights a global academic presence.
Leadership Roles: Holds multiple editorial board positions and leadership roles in prestigious medical societies, further emphasizing professional recognition.

Education 🎓

He earned his Doctorate in Clinical Medicine from the Peking University Health Science Center, where he was recognized as an “Excellent Graduate” and received the “Outstanding Scientific Research Award.”

Experience 💼

He honed his skills at Queen Mary Hospital of the University of Hong Kong, specializing in joint replacement technology. He has extensive experience in early treatment of osteonecrosis of the femoral head, hip preservation, osteoarthritis, rheumatoid arthritis, hip dysplasia, motor system injuries, total knee and hip replacements, as well as knee and shoulder arthroscopy.

Research Interests On Medicine 🔬

His research focuses on the diagnosis and treatment of osteonecrosis of the femoral head, hip preservation techniques, advancements in joint replacement, and improving outcomes in complex bone and joint diseases.

Awards 🏆

Excellent Graduate of Peking University
Outstanding Scientific Research Award, Peking University
First Prize, Battle of 100 Groups, China Association for Health Promotion and Education
Third Prize, Chinese Orthopedic Good Doctor Reading Contest, Chinese Journal of Bone and Joint Surgery
Excellent Prize, Speech Contest (Beijing), Editorial Committee of the Chinese version of JBJS

Publications 📖

He has authored 17 SCI articles and nearly 8 papers in core journals as the first or co-first author. Additionally, he participated in the compilation of three orthopedic books, such as “Osteonecrosis and Strategies for Diagnosis and Treatment of Joint Surgery.”

Title: Application, research hotspots, and shortcomings of degradable zinc-based alloys in bone defect repair and reconstruction
- Authors: Liu Haoyang, Xie Qiang, Shen Mengran, Yue Debo, Wang Weiguo
- Year: 2025
Title: Correction to: Extracellular Vesicles from BMSCs Prevent Glucocorticoid-Induced BMECs Injury by Regulating Autophagy via the PI3K/Akt/mTOR Pathway
- Authors: Ma Jinhui, Shen Mengran, Yue Debo, Gao Fuqiang, Wang Bailiang
- Year: 2024
Title: Editorial: New insight into immune cells in the development of non-traumatic osteonecrosis of the femoral head
- Authors: Zhou Yu, Ma Jinhui, Zhang Qingyu, Wang Bailiang
- Year: 2024
Title: Interleukin-33-mediated bone immunity
- Authors: Shen Mengran, Ren Yansong, Zhou Yu, Ma Jinhui, Wang Bailiang
- Year: 2023

Professional Contributions

He has led one Beijing Natural Science Youth Fund project, one China-Japan Friendship Hospital project, and contributed to three National Natural Science Foundation projects. His work also includes developing two utility model patents. Academically, he has presented at prestigious conferences like the Asian Association of Joint Replacement (ASIA), National Association of Orthopaedics (COA), and Beijing Orthopedic Association (BOA).

Professional Memberships 🔒

He serves as Secretary General of the Orthopedic Group of the Professional Committee of Translational Medicine of the Chinese Society of Microcirculation and holds memberships in:

Young and Middle-aged Editorial Committees of the Chinese Journal of Trauma, Chinese Journal of Reconstructive Surgery, Chinese Journal of Tissue Engineering, and Traditional Chinese Medicine Bone Setting.
Youth Working Committee of the Professional Committee of Translational Medicine, Chinese Society of Microcirculation.
Expert Committee on Bone Circulation and Osteonecrosis, Professional Committee of Shock Wave Medicine, Chinese Research Hospital Association.

Conclusion 🌟

His remarkable contributions to orthopedics, spanning clinical practice, research, and academic engagement, have made a lasting impact on the field. His passion for advancing orthopedic care and educating future generations continues to shape the future of bone and joint surgery.

Kevin Pak | Medicine | Best Researcher Award

Posted on 28/02/202528/02/2025 by sciencefather

Dr. Kevin Pak | Medicine | Best Researcher Award

Transplant Hepatology Fellow | UCLA | United States

Dr. Kevin C. Pak, M.D., is a distinguished transplant hepatologist affiliated with the Pflieger Liver Institute at the David Geffen School of Medicine at UCLA. With a strong background in internal medicine, gastroenterology, and hepatology, Dr. Pak has dedicated his career to advancing liver disease treatment and transplantation. His contributions to academic research and clinical practice have earned him recognition in the medical community.

Profile👤

Strengths for the Awards✨

✅ Exceptional Research Contributions: Dr. Pak has an extensive portfolio of peer-reviewed publications in prestigious journals, covering a range of topics in gastroenterology, hepatology, and military medicine. His research on hepatitis B, hepatocellular carcinoma, liver transplantation, and inflammatory bowel disease is particularly noteworthy.

✅ Clinical and Academic Leadership: As an Assistant Professor at USUHS and a former Chief Fellow in a gastroenterology fellowship, Dr. Pak has demonstrated strong mentorship and leadership in academic medicine. His contributions to teaching and training future physicians further emphasize his dedication to research and education.

✅ Recognized Excellence: Multiple honors and awards, including the AASLD Emerging Liver Scholar Award (2019) and Resident Researcher of the Year, highlight his significant impact in the field. His invited presentations and poster sessions at national and international conferences further validate his research reputation.

✅ Interdisciplinary and Military Medicine Contributions: His unique background in military medicine and research contributions in military healthcare settings (e.g., inflammatory bowel disease in active-duty personnel) provide a broader impact beyond civilian medicine.

Education 🎓

Dr. Pak began his academic journey at the United States Military Academy (USMA) in West Point, New York, earning a B.S. in Life Sciences. He then pursued his medical degree at the F. Edward Hébert School of Medicine at the Uniformed Services University of the Health Sciences (USUHS) in Bethesda, Maryland. His postgraduate training includes an Internal Medicine Residency at Walter Reed National Military Medical Center, followed by a Gastroenterology & Hepatology Fellowship at Naval Medical Center San Diego. He further specialized in Transplant Hepatology through a fellowship at the Pflieger Liver Institute at UCLA.

Experience 💼

Dr. Pak has held several academic positions, including Assistant Professor of Medicine and Teaching Fellow at USUHS. He is actively involved in medical education, mentoring students and residents. His clinical expertise spans hepatology, transplant medicine, and gastroenterology, making him a key contributor to the field. Additionally, Dr. Pak has served in the military, where he provided medical services in critical care settings.

Research Interests On Medicine🔬

Dr. Pak’s research focuses on liver disease, hepatocellular carcinoma, chronic hepatitis B, and liver transplantation. He is particularly interested in optimizing treatment strategies for liver disease and investigating emerging therapies. His work contributes to advancements in hepatology, improving patient outcomes and clinical practices.

Awards 🏆

Dr. Pak has received numerous accolades throughout his career. He was honored with the Resident Researcher of the Year Award and the AASLD Emerging Liver Scholar Award. His excellence in teaching earned him the James J. Leonard Award for Excellence in Teaching. In his military service, he received commendations such as the Navy/Marine Corps Commendation Medal and the Joint Service Commendation Medal.

Publications 📚

Dr. Pak has authored multiple peer-reviewed publications in prestigious journals. His notable works include:

Systematic review of safety of selective androgen receptor modulators in healthy adults: implications for recreational users
- Authors: JD Vignali, KC Pak, HR Beverley, JP DeLuca, JW Downs, AT Kress, …
- Publication Year: 2023
- Citations: 38
Wilson’s disease and iron overload: pathophysiology and therapeutic implications
- Authors: K Pak, S Ordway, B Sadowski, M Canevari, D Torres
- Publication Year: 2021
- Citations: 23
Helicobacter pylori Treatment Regimen Selection and Eradication Rates Across Department of Defense Patients for Fiscal Years 2016-2018
- Authors: ZC Junga, A Mertz, K Pak, M Singla
- Publication Year: 2023
- Citations: 9
The Patterns and Associated Cost of Serologic Testing for Helicobacter pylori in the U.S. Military Health System
- Authors: K Pak, Z Junga, A Mertz, M Singla
- Publication Year: 2020
- Citations: 6
State of the art: Test all for anti-hepatitis D virus and reflex to hepatitis D virus RNA polymerase chain reaction quantification
- Authors: E Umukoro, JJ Alukal, K Pak, J Gutierrez
- Publication Year: 2023
- Citations: 5
Occult HBV infection: a case series at a military treatment facility
- Authors: K Pak, S Ordway, D Torres
- Publication Year: 2020
- Citations: 4
An acute presentation of chronic gastric volvulus
- Authors: K Pak, Z Junga, P Young
- Publication Year: 2020
- Citations: 4
Decades of cough: Delayed recognition of atypical cystic fibrosis in an adult patient
- Authors: A Chandel, K Pak, S Dooley, K Salazar
- Publication Year: 2020
- Citations: 3
A small blemish: isotretinoin-induced microscopic colitis
- Authors: LR Dukate, K Pak, W O’Connell, Z Junga
- Publication Year: 2022
- Citations: 2
A Case of Whipple’s Disease With Concomitant Esophageal Candidiasis
- Authors: R Choi, A Pazevic, K Pak, M Skaret, A Bachmann, R Wilkerson
- Publication Year: 2024
- Citations: 1

Conclusion 🔍

Dr. Kevin C. Pak, M.D., is a dedicated physician, educator, and researcher in hepatology and gastroenterology. His commitment to advancing liver disease treatment, coupled with his academic and clinical expertise, makes him a key figure in the field. Through his research, mentorship, and clinical practice, Dr. Pak continues to contribute significantly to medical science and patient care.

Qianghua Lv | Medicine | Best Researcher Award

Posted on 25/02/202525/02/2025 by sciencefather

Prof. Dr. Qianghua Lv | Medicine | Best Researcher Award

Shandong Academy of Agricultural Sciences | China

Dr. Qianghua LV is an Associate Researcher at the Institute of Animal Science and Veterinary Medicine (IASVM), Shandong Academy of Agricultural Sciences (SAAS). He earned his Ph.D. in Veterinary Pharmacology under the mentorship of Prof. DENG Xuming at Jilin University in 2020. His research focuses on developing novel therapeutic strategies targeting bacterial virulence factors, including bacterial hemolysin, Type III Secretion System (T3SS), and Type IV Pili (TFP). His work contributes significantly to understanding anti-infective mechanisms and advancing new drug development against bacterial infections.

Profile👤

Strengths for the Awards✨

High-Impact Research Focus – Dr. LV Qianghua’s work on anti-infection mechanisms and natural compound-based drug development aligns with global health priorities, particularly in combating superbacterial infections. His research on bacterial virulence factors like hemolysin, T3SS, and TFP contributes to the development of novel antimicrobial strategies.
Quality Publications in Reputable Journals – He has multiple first-author and co-first-author publications in high-impact journals, such as Journal of Cellular and Molecular Medicine and Applied Microbiology and Biotechnology. These papers focus on novel antibacterial mechanisms and natural product inhibitors, demonstrating both innovation and scientific rigor.
Translational Impact – His research not only advances basic microbiology but also holds significant translational potential in developing new antibacterial therapies, an area of urgent medical need due to rising antibiotic resistance.
Collaborative and Multi-Disciplinary Approach – His collaborations with researchers across multiple disciplines (pharmacology, microbiology, and veterinary medicine) enhance the applicability of his findings beyond veterinary science, benefiting both animal and human health.
Contribution to Veterinary Medicine – As an Associate Researcher at the IASVM, SAAS, Dr. LV contributes significantly to veterinary pharmacology, a field essential for both agricultural and public health. His work has implications for livestock disease management and food safety, making it highly relevant for both academia and industry.

🎓 Education

Ph.D. in Veterinary Pharmacology, Jilin University, 2020
- Advisor: Prof. DENG Xuming
- Research Focus: Anti-infection mechanisms of natural compounds targeting bacterial virulence factors

💼 Experience

Associate Researcher, IASVM, SAAS (2020–Present)
- Conducting research on antibacterial strategies targeting virulence factors
- Screening natural compounds for inhibitory effects on bacterial infections
- Developing new therapeutic agents against superbacterial infections

🔬 Research Interests On Medicine

🦠 Discovery and screening of novel targets and lead compounds against superb acterial infections
💊 Synergistic antibacterial effects and mechanisms of natural compounds and antimicrobial agents

📚 Selected Publications

Title: Inhibition of the type III secretion system by syringaldehyde protects mice from Salmonella enterica serovar Typhimurium
Authors: Lv Q(#), Chu X(#), Yao X, Ma K, Zhang Y*, Deng X*
Publication Year: 2019
Journal: Journal of Cellular and Molecular Medicine
Title: Identification of the natural product paeonol derived from peony bark as an inhibitor of the Salmonella enterica serovar Typhimurium type III secretion system
Authors: Lv Q(#), Li S(#), Wei H, Wen Z, Wang Y, Tang T, Wang J, Xia L*, Deng X*
Publication Year: 2020
Journal: Applied Microbiology and Biotechnology
Title: Phloretin potentiates polymyxin E activity against Gram-negative bacteria
Authors: Du R(#), Lv Q(#), Hu W, Hou X, Zhou Y, Deng X, Sun L, Li L, Deng Y, Wang J
Publication Year: 2021
Journal: Life Sciences
Title: Commercialized artemisinin derivatives combined with colistin protect against critical Gram-negative bacterial infection
Authors: Zhou Y, Liu B, Chu X, Su J, Xu L, Li L, Deng X, Li D*, Lv Q*, Wang J*
Publication Year: 2022
Journal: Communications Biology
Title: Isoflavone glucoside genistin, an inhibitor targeting Sortase A and Listeriolysin O, attenuates the virulence of Listeria monocytogenes in vivo and in vitro
Authors: Liu M(#), Lv Q(#), Xu J, Liu B, Zhou Y, Zhang S, Shen X, Wang L
Publication Year: 2023
Journal: Biochemical Pharmacology

🔚 Conclusion

Dr. LV Qianghua has dedicated his research to developing innovative antibacterial strategies, focusing on targeting bacterial virulence factors. His contributions in natural compound screening and new drug development have advanced the fight against superbacterial infections. With numerous impactful publications and ongoing research, he continues to make significant strides in veterinary medicine and pharmacology.

Yang Xu | Medicine | Best Researcher Award

Posted on 08/02/202508/02/2025 by sciencefather

Dr. Yang Xu | Medicine | Best Researcher Award

Associate chief physician | Department of Respiratory and Critical Care Medicine, The Eighth Medical Center, Chinese PLA General Hospital | China

Yang Xu is an Associate Chief Physician, Associate Professor, and Graduate Supervisor at the Department of Respiratory and Critical Care Medicine, The Eighth Medical Center, Chinese PLA General Hospital. Specializing in the early diagnosis and personalized treatment of lung tumors, Dr. Xu has made significant contributions to respiratory medicine and oncology. As a leading expert in the field, he has played a pivotal role in advancing immune purification and cell therapy, earning widespread recognition for his scientific achievements.

Profile

Strengths for the Awards

✅ Expertise in Lung Tumor Diagnosis & Treatment: Yang Xu specializes in the early diagnosis and personalized treatment of lung tumors, which is a crucial area in respiratory and critical care medicine.

✅ Strong Research Contributions: With 6 funded research projects, including National Natural Science Foundation of China and key national R&D plans, his research impact is significant.

✅ Recognition & Patents: Winning 1 medical science and technology progress award and holding 4 national invention patents showcase his innovation and contribution to medical advancements.

✅ Publication Record: Publishing 40 research papers, including 20 SCI-indexed papers, and editing 5 monographs as a deputy principal author indicates a high level of scholarly contribution.

✅ Leadership & Influence: Holding leadership positions in prestigious medical associations such as the Chinese Medical Association and Beijing Medical Association reflects his influence in the field.

🎓 Education

Dr. Xu received his medical education and advanced training in respiratory and critical care medicine, equipping him with the expertise to diagnose and treat complex lung diseases. His academic journey has been marked by rigorous research and continuous professional development in cutting-edge medical technologies.

👨‍⚕️ Experience

With extensive experience in respiratory and critical care medicine, Dr. Xu has led multiple national research projects, including those funded by the National Natural Science Foundation of China and the national key R&D plan. As an esteemed educator and mentor, he has guided numerous students in the field, shaping the next generation of medical professionals. His leadership extends to prestigious roles such as Deputy Leader of the Immune Purification and Cell Therapy Group under the Chinese Medical Association and Deputy Chairman of the Lung Cancer Group in the Respiratory Branch of the Beijing Medical Association.

🔬 Research Interests On Medicine

Dr. Xu’s research focuses on:

Lung Tumor Diagnosis & Treatment – Advancing early detection and precision therapy.
Immune Checkpoint Inhibitor Pneumonia – Contributing to China’s first expert consensus.
Strategic Advanced Electronic Materials – Investigating innovative medical applications.
Immune Purification & Cell Therapy – Exploring novel therapeutic strategies in respiratory medicine.

🏆 Awards

Dr. Xu has received numerous accolades for his contributions to medical science, including:

Medical Science & Technology Progress Award 🏅
4 National Invention Patents 🏅🏅🏅🏅
Excellent Doctor & Excellent Teacher Titles 🏆 (Multiple times)
Selected as China’s High-Level Scientific and Technological Innovation Talent 🌟

📚 Publications

Clinic Examination and Gene Diagnosis for a Birt–Hogg–Dubé Syndrome Family With a Novel flcn Frameshift Mutation Causing Nonsense‐Mediated mRNA Degradation
- Authors: Yang Xu, Jie Gao, Yang An, Chenxi Zou, Guoqing Ding, Guohua Yang
- Year: 2025
[Clinical diagnosis and treatment of lung cancer combined with interstitial lung disease]
- Author: Xu Y
- Year: 2024
Integrative analysis of multi-omics data reveals the heterogeneity and signatures of immune therapy for small cell lung cancer
- Authors: Yabin Chen, Fang Z, Tang Y, Jin Y, Guo C, Hu L, Xu Y, Ma X, Gao J, Xie M et al.
- Year: 2021
Clinical characteristics of patients with chronic eosinophilic pneumonia in a Chinese tertiary-care hospital: A 6-year retrospective study
- Authors: Xu Y, Wang Z, Li W, Zhu Q, Liang Z
- Year: 2021
Radiographic features and prognosis of early- and late-onset non-small cell lung cancer immune checkpoint inhibitor-related pneumonitis
- Authors: Huang A, Xu Y, Zang X, Wu C, Gao J, Sun X, Xie M, Ma X, Deng H, Song J et al.
- Year: 2021
Perfluorocarbon Protects against Lipopolysaccharide-Induced Apoptosis of Endothelial Cells in Pulmonary Microvessels
- Authors: Xu Y, Wu T, Wang P, Liang ZX, Shi SS, Xu SF, Liu XJ, Tian Q
- Year: 2021
Lung cancer treatment in the era of immunotherapy
- Authors: Xu Y, Liang-an Chen
- Year: 2020
The efficacy and safety of low-frequency rotating static magnetic field therapy combined with chemotherapy on advanced lung cancer patients: a randomized, double-blinded, controlled clinical trial
- Authors: Minghui Zhu, Yang Z, Hang Yu, Zhu Q, Xu Y, Li Y, Li C, Zhao W, Zhixin Liang, Liang-an Chen
- Year: 2020
Identification of differentially expressed genes in hip cartilage with femoral head necrosis, based on genome‑wide expression profiles
- Authors: Li WC, Bai L, Xu Y, Xu RJ, Hou WB
- Year: 2019
Cystic and solitary nodular pulmonary metastases in a patient with low-grade endometrial stromal sarcoma: A case report and literature review

Authors: Xu Y, Zhixin Liang, Guo JT, Su X, Lu YL, Guan XZ
Year: 2019

🔚 Conclusion

Yang Xu is a distinguished leader in respiratory and critical care medicine, driving innovation in lung cancer treatment and immune-related diseases. His contributions to research, education, and clinical practice continue to shape the future of respiratory medicine, making a lasting impact on both national and global healthcare communities.

Mario Troisi | Medicine | Excellence in Innovation

Posted on 21/12/202421/12/2024 by sciencefather

Dr. Mario Troisi | Medicine | Excellence in Innovation

MD | University of Naples Federico II | Italy

Mario Troisi, MD, is an accomplished ophthalmologist and senior resident at the University of Naples Federico II, Italy. He graduated with distinction from the University of Salerno in Medicine and Surgery (110/110 cum laude). Dr. Troisi specializes in ocular surface diseases and corneal surgeries and has participated in numerous prestigious international fellowships, including a corneal fellowship at the University of Brescia and a cataract surgery program in Egypt. A prolific researcher and speaker, he has presented at over 30 national and international conferences. In 2024, Dr. Troisi received the ESCRS Trainee Bursary and the EVER Andrzej Grzybowski Award, highlighting his outstanding contributions to ophthalmology.

Profile

Orcid